Illumina reports progress in expanding global access to genomics and sustainability achievements in 2025.

Illumina released its 2025 Corporate Responsibility Report highlighting advances in making genomic medicine more accessible worldwide and its sustainability efforts. The company partnered with governments and institutions to support large-scale genomics projects and rare disease initiatives, while reducing its environmental footprint significantly. Illumina also maintained pay equity and increased employee volunteerism, impacting millions of STEM learners. Innovations in genomic technology and collaborations promise continued growth in personalized medicine and sustainable practices.